Vivanza Biosciences Approves Share Transfer from Suspense Account, Appoints New Company Secretary
Vivanza Biosciences Ltd., at its recent Board Meeting held on July 9, 2026, addressed several corporate matters, including the approval of a share transfer from the Unclaimed Suspense Account and the appointment of a new officer. The Board meeting, which ran from 15:15 P.M. to 15:30 P.M., considered and approved various operational updates.Key Decisions Made by the Board
The Board took several significant decisions regarding shareholder matters, compliance appointments, and strategic international projects.Share Transfer Approval
The directors reviewed and approved the release and transfer of shares from the Unclaimed Suspense Account. The approval pertains to 300 Equity Shares bearing Folio No. M00304, Certificate Nos. 28491, 28492, and 28493, spanning Distinctive Numbers 2847701-2847800, 2847801-2847900, and 2847901-2848000. These shares were transferred in favour of Ms. Manju Narendra Kothari upon satisfactory verification of her KYC documents by the Company and its Registrar and Share Transfer Agent (RTA).
Executive Appointment
The Board considered and approved the appointment of Mr. Vishal Sureshbhai Katarmal as a Company Secretary and Compliance Officer, effective from July 9, 2026.
Details regarding this appointment were provided:
| Particulars | Description |
|---|---|
| Reason for Appointment | The Board appointed Mr. Vishal Sureshbhai Katarmal (ACS: 78544) as Company Secretary and Compliance Officer. |
| Date of Appointment | July 9, 2026. |
| Profile Brief | CS Vishal Sureshbhai Katarmal is an Associate Member of the Institute of Company Secretaries of India with experience in matters related to the Companies Act, Listing Regulations, and allied laws. |
Strategic Cooperation in Kyrgyzstan
The Board also took note of an agreement providing for strategic cooperation concerning the establishment of a Plastic Film Manufacturing Project in the Kyrgyz Republic. Furthermore, the company took note of the DPT-3 Return of Deposit filed for the financial year ended on March 31, 2026.
Stock Price Movement
Vivanza Biosciences Ltd settled on Thursday at ₹1.90, recording a 2.70% rise in shares. The equity experienced some movement during the trading session, ranging between an intraday low of ₹1.82 and a high of ₹1.91.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.